Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: May 28, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Nanomedicine(s) under the microscope.

Ruth Duncan¹, Rogerio Gaspar

¹Polymer Therapeutics Lab., Centro de Investigación Príncipe Felipe, Av. Autopista del Saler 16 E-46012, Valencia, Spain. profruthduncan@btinternet.com

Molecular Pharmaceutics

|October 7, 2011

Summary

Nanomedicines, or nanosized therapeutics and imaging agents, offer revolutionary potential for diagnostics and treatments. This review critically examines current clinical applications and future prospects of nanomedicines, emphasizing practical design and regulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bridging the gap in trauma care across New Zealand.

The New Zealand medical journal·2025

Same author

A World Health Organization tool for assessing research ethics oversight systems.

Bulletin of the World Health Organization·2025

Same author

WHO-listed authorities (WLA) framework: transparent evidence-based approach for promoting regulatory reliance towards increased access to quality-assured medical products.

Frontiers in medicine·2024

Same author

Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation.

Vaccine·2022

Same author

Considerations in boosting COVID-19 vaccine immune responses.

Lancet (London, England)·2021

Same author

A comparison of major trauma admissions to Christchurch Hospital during and after COVID-19 lockdown in New Zealand.

The New Zealand medical journal·2021

Area of Science:

Nanotechnology
Medical Science
Pharmacology

Background:

Nanomedicines, including nanosized therapeutics and imaging agents, are viewed with both optimism for their revolutionary potential and concern regarding safety.
The field of rational nanomedicine design has existed for nearly 50 years, with over 40 products reaching clinical use.

Purpose of the Study:

To critically review nanomedicines currently in clinical use.
To examine emerging nanosized drugs, drug delivery systems, imaging agents, and theranostics.
To discuss key factors in the practical design and regulatory approval of nanomedicines.

Main Methods:

Literature review of clinical nanomedicine products.
Analysis of emerging nanomedicine technologies.

More Related Videos

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Related Experiment Videos

Last Updated: May 28, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Discussion of design principles and regulatory pathways.

Main Results:

Over 40 nanomedicine products have successfully transitioned from laboratory research to routine clinical application.
A diverse range of nanomedicines, including drug delivery systems and imaging agents, show significant future promise.

Conclusions:

Nanomedicines represent a balanced field, offering substantial healthcare benefits rather than extreme risks.
Successful translation requires careful design considerations and robust regulatory oversight to ensure patient safety and efficacy.